Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Two new update entries were added to the Study Record Updates on 2025-12-24 and 2025-12-23. Several earlier update dates (e.g., 2025-12-08 and 2025-12-05) were removed.
    Difference
    0.2%
    Check dated 2025-12-30T22:30:19.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A Maryland location was added under Locations, and the page revision updated to v3.3.3; the old Maryland Locations entry and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:40:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record now reflects December 2025 update dates (2025-12-08 and 2025-12-05). Earlier November dates (2025-11-20 and 2025-11-19) have been removed.
    Difference
    0.1%
    Check dated 2025-12-09T19:05:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications section wording was updated to clarify PubMed sourcing, with a new revision date added. No changes were made to the study design, eligibility criteria, or results.
    Difference
    0.3%
    Check dated 2025-11-25T10:56:26.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Deleted the government funding lapse notice warning that information may be out of date and transactions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:00:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No additions or deletions are evident in the page; the study record appears unchanged across sections such as Overview, Eligibility Criteria, Design, and Contacts.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:28.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.